Related Experiment Video
Updated: Mar 7, 2026

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Structural bowel damage in quiescent Crohn's disease
Marianne M Amitai1, Moran Zarchin2, Adi Lahat2
1Department of Diagnostic Imaging, Sheba Medical Center, Tel Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Israel.
Structural bowel damage in quiescent Crohn's disease remains stable over 14 months. This study assessed progression of structural bowel damage (SBD) using the Lemann index (LI) in patients with Crohn's disease.
Area of Science:
- Gastroenterology
- Inflammatory Bowel Disease Research
- Medical Imaging in IBD
Background:
- Crohn's disease (CD) can cause progressive structural bowel damage (SBD), leading to complications.
- Data on SBD progression in CD is limited.
- The Lemann index (LI) is a novel tool integrating clinical, endoscopic, and imaging data to assess SBD.
Purpose of the Study:
- To evaluate the progression of structural bowel damage (SBD) in patients with quiescent Crohn's disease (CD).
Main Methods:
- Prospective study of quiescent CD patients (CDAI<220 for ≥3 months).
- Repeated magnetic resonance enterography (MRE) and video capsule endoscopy (VCE) were performed.
- Structural bowel damage (SBD) assessed using the Lemann index (LI); progression defined as LI > 0.3.
Main Results:
- Significant SBD (LI > 4.8) was present in 21.4% of patients at baseline.
- Disease duration and prior CD-related surgery were associated with significant SBD.
- In patients with follow-up MRE (n=41), LI remained stable over a median of 14.8 months, showing negligible change.
Conclusions:
- Structural bowel damage (SBD) in patients with quiescent Crohn's disease (CD) is stable over a median follow-up of 14 months.
- The Lemann index (LI) indicates stability of SBD in this quiescent patient cohort.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...

